Agarwal Vineet

Chief Financial OfficerKorro Bio, Inc. (KRRO) · full profile →Form 4 · filed Nov 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$56K
Net Open-Market Flow
-$56K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 11, 2024Sell(S)800$70.00$56K0
Nov 11, 2024Option exercise(M)800$11.68$9K800

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 11, 2024Option exercise(M)800$031K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-125822) within minutes of acceptance. Every field above traces to the original document. Verify it directly: